As concerns over Influenza A (H1N1) rise we want to keep you informed on Millipore's preparedness. Millipore’s Global Operations group proactively monitors the latest news and threat levels and has implemented a Pandemic Preparedness Program. This web page will provide you with the latest information on Millipore’s efforts to ensure business continuity for our customers so that they can continue to make drugs and vaccines that will help maintain world health and safety.

Communications

• A Letter to Millipore Customers from Robert Shaw, Program Director Vaccines and Emerging Biotech

Plans and Programs

• Millipore’s Influenza A (H1N1) Virus Preparedness Program

Informational Websites

• Frequently Asked Questions
• Swine Flu (Influenza H1N1)

• Swine Flu
• Influenza Resources

Other Resources